← Back to Search

Cognitive Behavioral Therapy for Suicide Attempt Prevention

Waitlist Available
Led By LT Justin Baker, PhD
Research Sponsored by University of Utah
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
18 years of age or older
Be older than 18 years old
Screening 3 weeks
Treatment Varies
Follow Up assessed once per week until completion of treatment (average of 12 weeks) and at every 3 months through study completion (average of 2 years)
Awards & highlights

Study Summary

This trial is testing whether BCBT, a 12-week treatment, is more effective than PCT in preventing suicide attempts in Marines. The study will also compare indicators of depression, hopelessness, and psychological and neurocognitive mediators of treatment effects.

Who is the study for?
This trial is for U.S. military personnel and veterans who are at least 18 years old, can understand and speak English, and have had suicidal thoughts with intent to die or a suicide attempt in the last two weeks. It's not for those unable to consent or participate in outpatient treatment due to severe psychiatric conditions like psychosis or mania.Check my eligibility
What is being tested?
The trial tests if Brief Cognitive Behavioral Therapy (BCBT) over 12 weeks is more effective than Present-Centered Therapy (PCT) at preventing suicide attempts among participants. The study will also look into how these treatments impact suicidal ideation, depression, hopelessness, and certain psychological/neurocognitive functions over a follow-up of two years.See study design
What are the potential side effects?
While specific side effects aren't listed for therapies like BCBT and PCT, therapy can sometimes bring up uncomfortable emotions or memories as part of the healing process.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
I am 18 years old or older.


Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~assessed once per week until completion of treatment (average of 12 weeks) and at every 3 months through study completion (average of 2 years)
This trial's timeline: 3 weeks for screening, Varies for treatment, and assessed once per week until completion of treatment (average of 12 weeks) and at every 3 months through study completion (average of 2 years) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in number of suicide attempts from baseline
Secondary outcome measures
Change in suicidal ideation scores from baseline

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Brief Cognitive Behavioral TherapyExperimental Treatment2 Interventions
Group II: Present-Centered TherapyActive Control2 Interventions
First Studied
Drug Approval Stage
How many patients have taken this drug
Brief Cognitive Behavioral Therapy (BCBT)
Treatment as Usual (TAU)
Completed Phase 4

Find a Location

Who is running the clinical trial?

Medical University of South CarolinaOTHER
932 Previous Clinical Trials
7,393,960 Total Patients Enrolled
Ohio State UniversityOTHER
827 Previous Clinical Trials
502,451 Total Patients Enrolled
United States Department of DefenseFED
861 Previous Clinical Trials
226,894 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this research project actively seeking participants at the present time?

"According to the clinicaltrials.gov database, this specific medical trial is not currently searching for patients. The original posting was on January 22nd 2020 and it has been edited as recently as October 5th 2022; however, there are other 219 trials actively seeking participants at present."

Answered by AI
Recent research and studies
~68 spots leftby Aug 2025